Skip to Content

Pilopine HS Dosage

Generic name: PILOCARPINE HYDROCHLORIDE 40mg in 1g
Dosage form: ophthalmic gel

Medically reviewed on July 25, 2017.

More

Apply a one-half inch ribbon in the lower conjunctival sac of the affected eye(s) once a day at bedtime.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Next → Professional

More about Pilopine HS (pilocarpine ophthalmic)

Consumer resources

Other brands: Pilocar, Isopto Carpine, Pilostat, Ocu-Carpine

Professional resources

Related treatment guides

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

Drug Class

Ophthalmic glaucoma agents

Related Drugs

Glaucoma, Open Angle epinephrine ophthalmic, timolol ophthalmic, Lumigan, Travatan, Xalatan, latanoprost ophthalmic, More...

Glaucoma, Narrow Angle pilocarpine ophthalmic, Pilostat, Isopto Carpine, More...

Glaucoma nadolol, acetazolamide, Combigan, pilocarpine ophthalmic, Diamox, mitomycin ophthalmic, More...

Intraocular Hypertension timolol ophthalmic, Lumigan, Travatan, Xalatan, latanoprost ophthalmic, brimonidine ophthalmic, More...

1 more conditions...

Pilopine HS Rating

No reviews - Add your review

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions & Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Aug 2nd, 2018), Cerner Multum™ (updated Aug 6th, 2018), Wolters Kluwer™ (updated Aug 3rd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.